Theralase Technologies, Inc. (TLTFF) Starts Presentation at the 2017 Marcum Microcap Conference
Theralase Technologies (OTC: TLTFF) designs, manufactures, markets and distributes patented super-pulsed laser technology indicated for the treatment of chronic knee pain and in off-label use the elimination of pain, reduction of inflammation and dramatic acceleration of tissue healing for numerous nerve, muscle and joint conditions. Theralase’s Photo Dynamic Therapy Division researches and develops specially designed molecules called Photo Dynamic Compounds, which are able to localize to cancer cells and then when laser light activated, effectively destroy them. For more information, visit the company's website at www.theralase.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users (1) access…







